Tangwei Wu

1.1k total citations
20 papers, 803 citations indexed

About

Tangwei Wu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Tangwei Wu has authored 20 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Tangwei Wu's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (7 papers). Tangwei Wu is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (7 papers). Tangwei Wu collaborates with scholars based in China and United States. Tangwei Wu's co-authors include Shuiyi Liu, Zhongxin Lu, Hui Hu, Weiqun Chen, Yong Ning, Xiaoyi Li, Deyong Kong, Chao Zheng, Zheqiong Tan and Zhenzhao Luo and has published in prestigious journals such as Scientific Reports, FEBS Letters and Carcinogenesis.

In The Last Decade

Tangwei Wu

19 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tangwei Wu China 12 576 514 99 78 71 20 803
Shunjie Xia China 9 534 0.9× 399 0.8× 86 0.9× 50 0.6× 68 1.0× 13 731
Yuqing Zhang China 15 604 1.0× 553 1.1× 119 1.2× 71 0.9× 36 0.5× 25 848
Rongkun Li China 15 420 0.7× 260 0.5× 111 1.1× 99 1.3× 43 0.6× 25 589
Zhigui Zuo China 14 432 0.8× 311 0.6× 147 1.5× 43 0.6× 47 0.7× 20 642
Lisi Zeng China 14 590 1.0× 467 0.9× 171 1.7× 61 0.8× 66 0.9× 31 865
Weihao Li China 14 558 1.0× 435 0.8× 135 1.4× 75 1.0× 32 0.5× 40 816
Lu Zang China 12 716 1.2× 448 0.9× 216 2.2× 81 1.0× 72 1.0× 26 923
Xue Guan China 17 610 1.1× 493 1.0× 50 0.5× 64 0.8× 35 0.5× 29 757

Countries citing papers authored by Tangwei Wu

Since Specialization
Citations

This map shows the geographic impact of Tangwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tangwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tangwei Wu more than expected).

Fields of papers citing papers by Tangwei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tangwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tangwei Wu. The network helps show where Tangwei Wu may publish in the future.

Co-authorship network of co-authors of Tangwei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Tangwei Wu. A scholar is included among the top collaborators of Tangwei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tangwei Wu. Tangwei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Kun, Tangwei Wu, Chao Zheng, et al.. (2025). Aptamer-functionalized graphene quantum dots combined with artificial intelligence detect bacteria for urinary tract infections. Frontiers in Cellular and Infection Microbiology. 15. 1555617–1555617. 4 indexed citations
2.
Zhao, Dan, et al.. (2024). Role of non-coding RNAs mediated pyroptosis on cancer therapy: a review. Expert Review of Anticancer Therapy. 24(5). 239–251.
3.
Chen, Heming, Xiaoyi Li, Weiqun Chen, Tangwei Wu, & Shuiyi Liu. (2024). LncRNA HOTAIR Inhibits miR-19a-3p to Alleviate Foam Cell Formation and Inflammatory Response in Atherosclerosis. International Journal of Medical Sciences. 21(3). 521–529. 5 indexed citations
4.
Wu, Tangwei, et al.. (2023). Huaier suppresses cell viability, migration and invasion in human non-small cell lung cancer via lncRNA DLEU2/miR-212-5p/ELF3 axis. International Journal of Medical Sciences. 21(2). 319–331. 1 indexed citations
5.
Yuan, Xiang, Hui Liu, Hao Hu, et al.. (2022). LINC00094/miR-19a-3p/CYP19A1 axis affects the sensitivity of ER positive breast cancer cells to Letrozole through EMT pathway. Aging. 14(11). 4755–4768. 13 indexed citations
6.
Liu, Shuiyi, Weiqun Chen, Hui Hu, et al.. (2021). Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1. Breast Cancer Research. 23(1). 115–115. 24 indexed citations
7.
Tan, Zheqiong, Man Zhu, Zhenzhao Luo, et al.. (2021). Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer. BMC Cancer. 21(1). 409–409. 29 indexed citations
8.
Li, You, Hui Hu, Yan Ge, et al.. (2020). Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules. Bioscience Reports. 40(2). 6 indexed citations
9.
Li, You, Yibin Zhang, Hui Hu, et al.. (2020). Colorectal Cancer Screening Methods and Molecular Markers for Early Detection. Technology in Cancer Research & Treatment. 19. 1079248074–1079248074. 41 indexed citations
10.
Wang, Hui, Zheqiong Tan, Hui Hu, et al.. (2019). microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1. BMC Cancer. 19(1). 738–738. 215 indexed citations
11.
Zhu, Man, Zheqiong Tan, Zhenzhao Luo, et al.. (2019). Association of the vitamin D metabolism gene GC and CYP27B1 polymorphisms with cancer susceptibility: a meta-analysis and trial sequential analysis. Bioscience Reports. 39(9). 11 indexed citations
12.
Hu, Hui, Qin Zhang, Weiqun Chen, et al.. (2019). MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5. Carcinogenesis. 41(4). 502–514. 51 indexed citations
13.
Wu, Tangwei, Hui Hu, Tianzhu Zhang, et al.. (2019). miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 53 indexed citations
14.
Tan, Zheqiong, Man Zhu, Zhenzhao Luo, et al.. (2019). Carnitine Palmitoyl Transferase 1A Is a Novel Serum Biomarker for the Diagnosis of Breast Cancer. SSRN Electronic Journal. 1 indexed citations
15.
Zhang, Tianzhu, Hui Hu, Yan Ge, et al.. (2019). Long Non-Coding RNA and Breast Cancer. Technology in Cancer Research & Treatment. 18. 1078111537–1078111537. 71 indexed citations
16.
Li, Xiaoyi, Deyong Kong, Heming Chen, et al.. (2016). miR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1. Scientific Reports. 6(1). 21789–21789. 133 indexed citations
17.
Wang, Hui, Shuiyi Liu, Tangwei Wu, et al.. (2015). Expression of miR-145 in breast cancer and its role in invasion and migration of breast cancer cells. Zhonghua jianyan yixue zazhi. 38(3). 186–190. 1 indexed citations
18.
Wu, Tangwei, Weiqun Chen, Deyong Kong, et al.. (2015). miR-25 targets the modulator of apoptosis 1 gene in lung cancer. Carcinogenesis. 36(8). 925–935. 62 indexed citations
19.
Wu, Tangwei, Weiqun Chen, Shuiyi Liu, et al.. (2014). Huaier suppresses proliferation and induces apoptosis in human pulmonary cancer cells via upregulation of miR‐26b‐5p. FEBS Letters. 588(12). 2107–2114. 70 indexed citations
20.
Lin, Chu‐Hsing, et al.. (2012). A Cloud-aided RSA Signature Scheme for Sealing and Storing the Digital Evidences in Computer Forensics. International Journal of Security and Its Applications. 6(2). 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunjie Xia Breakdown of academic impact, for papers by Yuqing Zhang Breakdown of academic impact, for papers by Rongkun Li Breakdown of academic impact, for papers by Zhigui Zuo Breakdown of academic impact, for papers by Lisi Zeng Breakdown of academic impact, for papers by Weihao Li Breakdown of academic impact, for papers by Lu Zang Breakdown of academic impact, for papers by Xue Guan
Rankless by CCL
2026